Connect with others who understand.

sign up log in
About MyOvarianCancerTeam

Connect with others who understand.

sign up log in
About MyOvarianCancerTeam

List of Treatments for Ovarian Cancer

Below is a listing of treatments and therapies for ovarian cancer. Click on one to read more information or connect with others currently using it.

View:

Avastin (Bevacizumab)

Overview
Avastin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat lung, colorectal, breast, and several other cancers. Avastin is sometimes prescribed off-label to treat ovarian read more

Clinical Trials

Overview
Depending on several factors, you may be eligible to participate in clinical trials studying new treatments for ovarian cancer. Clinical trials are the only way new treatments for ovarian cancer can be tested.… read more

Exercise

Overview
Regular physical activity has been shown to benefit people with ovarian cancer in many ways. Exercise can improve quality of life during and after treatment. Being physically active helps reduce fatigue and… read more

Lynparza (Olaparib)

Overview
Lynparza is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat deleterious germline or somatic BRCA-mutated advanced ovarian cancer who are in complete or partial response to… read more

Nutrition

Overview
Everyone feels their best when they consistently eat a healthy, balanced diet. For people with ovarian cancer, good nutrition can help you recover from treatment, reduce treatment side effects, support bone… read more

Rozlytrek (Entrectinib)

Overview
Rozlytrek is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancerous tumors that have a neurotrophic tyrosine receptor kinase (NTRK) gene fusion without a known resistance… read more

Rubraca (Rucaparib)

Overview
Rubraca is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adult patients with recurrent epithelial ovarian cancer who are in a complete or partial… read more

Vitrakvi (Larotrectinib)

Overview
Vitrakvi is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known resistance… read more

Zejula (Niraparib)

Overview
Zejula is a prescription drug approved by the U.S. Food and Drug Administration (FDA) for the maintenance treatment of adults with advanced or recurrent epithelial ovarian cancer who are in a complete or… read more

Already a Member? Log in